Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

NCT02623062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

644

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastro-esophageal Reflux Disease (GERD)

Interventions

DRUG: Compound Sodium Alginate Oral Suspension sachet
DRUG: Matched placebo

Sponsor

Reckitt Benckiser Healthcare (UK) Limited